# Adaptimmune Therapeutics PLC: Form 8-K, filed Mar 13, 2017

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2017-03-13
- Accepted by EDGAR: Mar 13, 2017, 07:43 ET
- Period: 2017-03-13
- Accession: 0001104659-17-015968
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465917015968/a17-8188_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465917015968/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465917015968/a17-8188_18k.htm

Filed Mar 13, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-015968. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
